On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)
Samia Mora, Robert J Glynn, S Matthijs Boekholdt, Børge G Nordestgaard, John J P Kastelein, Paul M Ridker
70Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)'. Sammen danner de et unikt fingeraftryk.